WILMINGTON, DE — Incyte (Nasdaq: INCY) will release its second-quarter 2026 financial results on July 28 before U.S. markets open, with executives scheduled to discuss the results during an investor conference call later that morning, the company announced.
The Wilmington-based biopharmaceutical company plans to issue its earnings release at 7 a.m. Eastern time, followed by a conference call and webcast at 8 a.m. Eastern.
Investors and analysts can participate in the conference call by dialing 877-407-3042 within the United States or 201-389-0864 internationally using conference ID 13759527.
A live webcast accompanied by presentation slides will be available through Incyte’s investor relations website at Investor.Incyte.com. The webcast replay will remain available for 90 days.
For those unable to join the live conference call, a telephone replay will be available for 30 days by calling 877-660-6853 within the United States or 201-612-7415 internationally and entering conference ID 13759527.
The quarterly update is expected to provide investors with financial results and an overview of developments across Incyte’s portfolio of medicines and product pipeline spanning hematology, oncology, and inflammation and autoimmunity.
Support the local news that supports Chester County. MyChesCo delivers reliable, fact-based reporting and essential community resources—free for everyone. If you value that, click here to become a patron today.